27
Jul
#NephroPlusIPO #HealthcareIPO #DialysisServices #IndianHealthcare #KidneyCare #IPOAlert #SEBIUpdate #ChronicKidneyDisease #HealthTechIndia #InvestInHealthcare #Nephrocare #IPO2025 Chandigarh — Nephrocare Health Services Limited, widely recognized by its brand NephroPlus, Asia’s largest dialysis services provider and the world’s fifth largest by number of treatments in FY25, has officially filed its Draft Red Herring Prospectus (DRHP) with the Securities and Exchange Board of India (SEBI). This marks a significant step toward its much-anticipated Initial Public Offering (IPO). The Hyderabad-headquartered company is aiming to raise ₹353.4 crores via a fresh issue of equity shares, while also executing an Offer for Sale (OFS) of up to 1.27 crore equity shares…